Vertical disintegration: a strategy for pharmaceutical businesses in 2009?
2009; Nature Portfolio; Volume: 8; Issue: 6 Linguagem: Inglês
10.1038/nrd2914
ISSN1474-1784
AutoresJohn Dixon, Geoff Lawton, Peter Machin,
Tópico(s)Biotechnology and Related Fields
ResumoEnhancing the productivity of drug R&D might be achieved by vertical disintegration of pharmaceutical business into drug discovery, development and marketing organizations.
Referência(s)